XML 125 R110.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity - Earnings Per Share ("EPS") (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Basic      
Net income attributable to common stockholders $ 223,272 $ 330,065 $ 284,829
Weighted average shares outstanding (in shares) 188,701,149 184,641,642 165,355,167
Net income per common share (in dollars per share) $ 1.18 $ 1.79 $ 1.72
Diluted      
Net income attributable to common stockholders $ 223,272 $ 330,065 $ 284,829
Net income attributable to noncontrolling interest 19,278 29,122 28,044
Interest expense on convertible notes 0 24,832 20,166
Net income attributable to common stockholders and noncontrolling interest $ 242,550 $ 384,019 $ 333,039
Weighted average shares outstanding (in shares) 188,701,149 184,641,642 165,355,167
Dilutive effect of OP Units (in shares) 16,293,589 16,293,589 16,304,638
Dilutive effect of restricted stock units (in shares) 0 17,294,392 552,621
Dilutive effect of convertible notes (in shares) 531,872 613,990 16,900,204
Weighted average shares outstanding (in shares) 205,526,610 218,843,613 199,112,630
Diluted earnings per common share (in dollars per share) $ 1.18 $ 1.75 $ 1.67
Convertible senior unsecured notes      
Diluted      
Potentially dilutive shares (in shares) 17,487,435    
Convertible senior unsecured notes      
Diluted      
Interest expense $ 24,300 $ 24,800 $ 19,800
Mr. Ivan Kaufman | Performance-Based Restricted Stock      
Diluted      
Vesting period (in years) 4 years